Cleared Traditional

K862649 - CYTOTECH CIC ENZYME IMMUNOASSAY
(FDA 510(k) Clearance)

Sep 1986
Decision
55d
Days
Class 2
Risk

K862649 is an FDA 510(k) clearance for the CYTOTECH CIC ENZYME IMMUNOASSAY. This device is classified as a Complement C1q, Antigen, Antiserum, Control (Class II - Special Controls, product code DAK).

Submitted by Cytotech, Inc. (San Diego, US). The FDA issued a Cleared decision on September 4, 1986, 55 days after receiving the submission on July 11, 1986.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5240.

Submission Details

510(k) Number K862649 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 1986
Decision Date September 04, 1986
Days to Decision 55 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary

Device Classification

Product Code DAK — Complement C1q, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5240

Similar Devices — DAK Complement C1q, Antigen, Antiserum, Control

All 27
BINDAZYME CLQ CIC EIA KIT
K031563 · The Binding Site, Ltd. · Sep 2003
IBL C1Q-CIC CIA TEST
K032254 · Ibl GmbH · Aug 2003
CIC-C1Q EIA
K012576 · American Laboratory Products Co., Ltd. · Jan 2002
THYMOSTAT ELISA FOR THE DETECTION OF HUMAN IGG,M AND A ANTI-RABBIT IGG ANTIBODIES
K973203 · Sangstat Medical Corp. · Sep 1998
IMMUSTRIP HAMA IGG
K972873 · Immunomedics, Inc. · Mar 1998
HUMAN C1Q RADIAL IMMUNODIFFUSION KIT
K951968 · Kent Laboratories, Inc. · May 1995